Business Description
Tsumura & Co
ISIN : JP3535800001
Total Employee Number:
5,014Compare
Compare
Traded in other countries / regions
4540.JapanTSUA.GermanyTSMRF.USA IPO Date
2026-01-12Description
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates the majority of its revenue through prescription Kampo products, followed by over-the-counter medicines. It promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company specializes in developing, producing, and marketing Kampo formulations that integrate traditional herbal knowledge with modern pharmaceutical science to address various health conditions.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.62 | |||||
Equity-to-Asset | 0.54 | |||||
Debt-to-Equity | 0.42 | |||||
Debt-to-EBITDA | 2.45 | |||||
Interest Coverage | 33.48 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.45 | |||||
Beneish M-Score | -2.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.1 | |||||
3-Year EBITDA Growth Rate | 18.5 | |||||
3-Year EPS without NRI Growth Rate | 18.5 | |||||
3-Year Book Growth Rate | 9.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.75 | |||||
9-Day RSI | 52.66 | |||||
14-Day RSI | 53.09 | |||||
3-1 Month Momentum % | 2.13 | |||||
6-1 Month Momentum % | -8.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.19 | |||||
Quick Ratio | 2.22 | |||||
Cash Ratio | 1.01 | |||||
Days Inventory | 522.84 | |||||
Days Sales Outstanding | 138.32 | |||||
Days Payable | 89.67 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.17 | |||||
3-Year Dividend Growth Rate | 31.9 | |||||
Forward Dividend Yield % | 4.31 | |||||
5-Year Yield-on-Cost % | 5.65 | |||||
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | -9.67 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 47.51 | |||||
Operating Margin % | 18.29 | |||||
Net Margin % | 14.6 | |||||
EBITDA Margin % | 28.63 | |||||
FCF Margin % | -5.01 | |||||
OCF Margin % | 12.61 | |||||
ROE % | 9.31 | |||||
ROA % | 5.43 | |||||
ROIC % | 6.39 | |||||
3-Year ROIIC % | 5.53 | |||||
ROC (Joel Greenblatt) % | 12.87 | |||||
ROCE % | 9.81 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 10.26 | |||||
Forward PE Ratio | 10.24 | |||||
PE Ratio without NRI | 10.54 | |||||
Shiller PE Ratio | 14.4 | |||||
Price-to-Owner-Earnings | 23.37 | |||||
PEG Ratio | 0.72 | |||||
PS Ratio | 1.5 | |||||
PB Ratio | 0.9 | |||||
Price-to-Tangible-Book | 1.07 | |||||
Price-to-Operating-Cash-Flow | 11.67 | |||||
EV-to-EBIT | 9.32 | |||||
EV-to-EBITDA | 7.1 | |||||
EV-to-Revenue | 2.02 | |||||
EV-to-FCF | -39.78 | |||||
Price-to-GF-Value | 0.91 | |||||
Price-to-Projected-FCF | 1.08 | |||||
Price-to-Median-PS-Value | 0.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.79 | |||||
Price-to-Graham-Number | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 3.71 | |||||
Earnings Yield (Greenblatt) % | 10.74 | |||||
FCF Yield % | -3.34 | |||||
Forward Rate of Return (Yacktman) % | 13.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tsumura & Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,089.655 | ||
| EPS (TTM) (€) | 2.12 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 53.09 | ||
| 14-Day ATR (€) | 0.286661 | ||
| 20-Day SMA (€) | 19.635 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 18 - 23 | ||
| Shares Outstanding (Mil) | 74.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tsumura & Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tsumura & Co Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| JPY 79.000000 Cash Dividend | 2026-09-29 | In 56 days | ||
| JPY 79.000000 Cash Dividend | 2026-03-30 | 19.80 (+0.00%) |
Show
Entries
Tsumura & Co Frequently Asked Questions
What is Tsumura & Co(FRA:TSUA)'s stock price today?
The current price of FRA:TSUA is €19.80. The 52 week high of FRA:TSUA is €23.00 and 52 week low is €18.00.
When is next earnings date of Tsumura & Co(FRA:TSUA)?
The next earnings date of Tsumura & Co(FRA:TSUA) is .
Does Tsumura & Co(FRA:TSUA) pay dividends? If so, how much?
The Dividend Yield %  of Tsumura & Co(FRA:TSUA) is 2.17% (As of Today), Highest Dividend Payout Ratio of Tsumura & Co(FRA:TSUA) was 0.4. The lowest was 0.26. And the median was 0.35. The  Forward Dividend Yield % of Tsumura & Co(FRA:TSUA) is 4.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Tsumura & Co
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers